Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Non-Current Deferred Tax Liability (2023)

Day One Biopharmaceuticals (DAWN) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $75000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A to $75000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $75000.0, a N/A change, with the full-year FY2023 number at $75000.0, changed N/A from a year prior.
  • Non-Current Deferred Tax Liability was $75000.0 for Q4 2023 at Day One Biopharmaceuticals.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $75000.0 in Q4 2023 to a low of $75000.0 in Q4 2023.